Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erector spinae block with ropivacaine vs ropivacaine + epinephrine in lumbar spine fusion
IRCT20210415050983N12Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in lumbosacral disc disease comparing Ropivacaine ESPB with Ropivacaine + epinephrine ESPB (2 arms). Primary endpoints: Intraoperative bleeding volume and Duration of postoperative analgesia. Started Sep 2025; status: completed.
02
Drugs
ropivacaineepinephrine
03
Conditions
lumbosacral disc disease
Beyond the preview
Go deeper on IRCT20210415050983N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210415050983N12.